- |||||||||| LY3435151 / Eli Lilly
Enrollment change, Trial termination, Metastases: A Study of LY3435151 in Participants With Solid Tumors (clinicaltrials.gov) - Apr 14, 2020
P1a/1b, N=2, Terminated,
N=230 --> 2 | Recruiting --> Terminated; Study terminated due to strategic business decision by Eli Lilly and Company.
- |||||||||| LY3435151 / Eli Lilly
Trial completion date, Trial primary completion date, Metastases: A Study of LY3435151 in Participants With Solid Tumors (clinicaltrials.gov) - Mar 3, 2020
P1a/1b, N=230, Recruiting,
N=230 --> 2 | Recruiting --> Terminated; Study terminated due to strategic business decision by Eli Lilly and Company. Trial completion date: Jan 2023 --> Jun 2020 | Trial primary completion date: Jan 2023 --> Jun 2020
- |||||||||| LY3435151 / Eli Lilly
Enrollment open, Metastases: A Study of LY3435151 in Participants With Solid Tumors (clinicaltrials.gov) - Nov 9, 2019
P1a/1b, N=230, Recruiting,
Trial completion date: Jan 2023 --> Jun 2020 | Trial primary completion date: Jan 2023 --> Jun 2020 Not yet recruiting --> Recruiting
|
